Group One Trading’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Group One Trading’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-14,900	Closed	-$5K	–	6021
2018 Q2	$5K	Hold	14,900	–	–	﹤0.01%	4836
2018 Q1	$22K	Sell	14,900 -4,000	-21%	-$6.98K	﹤0.01%	4062
2017 Q4	$27K	Hold	18,900	–	–	﹤0.01%	4046
2017 Q3	$43K	Sell	18,900 -28,300	-60%	-$37.9K	﹤0.01%	3721
2017 Q2	$64K	Sell	47,200 -1,500	-3%	-$2.17K	﹤0.01%	3381
2017 Q1	$104K	Sell	48,700 -500	-1%	-$1.88K	﹤0.01%	2954
2016 Q4	$217K	Sell	49,200 -76,500	-61%	-$363K	﹤0.01%	2372
2016 Q3	$610K	Buy	+125,700	New	+$573K	0.01%	1671
2016 Q2	–	Sell	-46,700	Closed	-$166K	–	5369
2016 Q1	$166K	Buy	+46,700	New	+$241K	﹤0.01%	2455

Other funds holding ARLZ

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Group One Trading's ARLZ Position: Q3 2018 in Review

Group One Trading sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 45,671 shares — an estimated $16K sold.

Group One Trading first reported a position in ARLZ in Q1 2016 and held it in 9 quarters. The position peaked at $480K in Q4 2016. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

Group One Trading reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
Group One Trading sold 45,671 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $16K.
Group One Trading first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 9 quarters.
Group One Trading's Aralez Pharmaceuticals Inc. position peaked at $480K in Q4 2016.
4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Group One Trading's 13F filing for Q3 2018, filed 8 Nov 2018.